1. Home
  2. TYRA vs WOLF Comparison

TYRA vs WOLF Comparison

Compare TYRA & WOLF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tyra Biosciences Inc.

TYRA

Tyra Biosciences Inc.

SELL

Current Price

$19.70

Market Cap

1.3B

Sector

Health Care

ML Signal

SELL

Logo Wolfspeed Inc.

WOLF

Wolfspeed Inc.

SELL

Current Price

$22.92

Market Cap

1.5B

Sector

Technology

ML Signal

SELL

Company Overview

Basic Information
Metric
TYRA
WOLF
Founded
2018
1987
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Semiconductors
Sector
Health Care
Technology
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.5B
IPO Year
2021
2025

Fundamental Metrics

Financial Performance
Metric
TYRA
WOLF
Price
$19.70
$22.92
Analyst Decision
Strong Buy
Hold
Analyst Count
15
2
Target Price
★ $47.45
$24.00
AVG Volume (30 Days)
577.7K
★ 2.7M
Earning Date
11-10-2026
11-04-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
★ N/A
EPS
★ N/A
N/A
Revenue
N/A
★ $1,385,982,000.00
Revenue This Year
N/A
$14.87
Revenue Next Year
N/A
$4.07
P/E Ratio
★ N/A
N/A
Revenue Growth
N/A
★ 19.00
52 Week Low
$15.94
$13.49
52 Week High
$40.65
$80.82

Technical Indicators

Market Signals
Indicator
TYRA
WOLF
Relative Strength Index (RSI) 41.01 45.06
Support Level $18.46 $19.36
Resistance Level $22.69 $26.70
Average True Range (ATR) 1.19 2.32
MACD -0.10 0.14
Stochastic Oscillator 12.33 42.84

Price Performance

Historical Comparison
TYRA
WOLF

About TYRA Tyra Biosciences Inc.

Tyra Biosciences Inc is a clinical-stage biotechnology company focused on developing next-generation precision medicines for large opportunities in targeted oncology and genetically defined conditions, harnessing the power of Fibroblast Growth Factor Receptor (FGFR) biology. The company's in-house precision medicine platform, SNAP, enables rapid and precise drug design through iterative molecular SNAPshots that help to design and predict which product candidates may demonstrate the highest potency, selectivity, and tolerability in the clinic. The various drug candidates in the company's product pipeline are FGFR3, FGFR4/3, and FGFR1/2/3: three clinical-stage, novel small molecules designed to overcome the toxicity and resistance liabilities of first-generation pan-FGFR inhibitors.

About WOLF Wolfspeed Inc.

Wolfspeed Inc is an innovator of wide bandgap semiconductors, focused on silicon carbide materials and devices for power applications. Its product families include silicon carbide materials and power devices. Its products are targeted for various applications in the Automotive domain, including electric vehicles and fast charging, as well as existing and emerging applications in the Industrial & Energy domain such as AI data centers, grid modernization and renewable energy and storage as well as aerospace and defense. The company also use contract manufacturers, some of which include captive lines, for certain products and aspects of product fabrication, assembly and packaging. The company has one reportable segment. Majority of revenue comes from United States followed by Hong Kong.

Share on Social Networks: